Does Extended Interval Dosing Natalizumab Preserve Effectiveness in Multiple Sclerosis? A 7 Year-Retrospective Observational Study
- Riancho, J.
- Setien, S.
- Sánchez de la Torre, J.R.
- Torres-Barquin, M.
- Misiego, M.
- Pérez, J.L.
- Castillo-Triviño, T.
- Menéndez-García, C.
- Delgado-Alvarado, M.
Journal:
Frontiers in Immunology
ISSN: 1664-3224
Year of publication: 2021
Volume: 12
Type: Article
